drugset / Trial / NCT05742919
A Research Study Looking at How a Single Dose of the Medicine NNC0194-0499 Behaves in Chinese Men
RandomizedParallel-groupOpen-labelTreatment
Summary
This study looks at how a new study medicine called NNC0194-0499 behaves in the body of Chinese men. Three different dose levels will be tested. Participant will get only one of the three different dose levels of NNC0194-0499. Which dose participant will get will be decided by chance. NNC0194-0499 is a medicine under clinical investigation. It means that the medicine has not yet been approved by the health authorities. Participant will get 1 or 2 injections of the study medicine. It will be injected with a needle into a skin fold on stomach. The study will last for a maximum of 64 days. Participant will not be able to take part in the study if the study doctor considers there is a risk for participant's health.
Timeline
- Start
- 2023-02-16
- Primary completion
- 2023-06-13
- Completion
- 2023-06-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | zalfermin | Protein / enzyme biologic | 12 mg | Subcutaneous |
| Subject | zalfermin | Protein / enzyme biologic | 30 mg | Subcutaneous |
| Subject | zalfermin | Protein / enzyme biologic | 96 mg | Subcutaneous |